Skip to main content

MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course

  • Conference paper
Amine Oxidases and Their Impact on Neurobiology

Part of the book series: Journal of Neural Transmission ((NEURAL SUPPL,volume 32))

  • 98 Accesses

Summary

In rabbits, 3mg/kg Ro 19-6327 p.o., induced complete monoamine oxidase type B (MAO-B) inhibition in striatum, cerebral cortex, liver and platelets for about 12 h. In healthy human volunteers complete inhibition of platelet MAO was obtained with only 5 mg Ro 19-6327. After 40 and 200 mg Ro 19-6327 the duration of complete MAO-B inhibition was prolonged to 12 and 24 hours, respectively. Changes in brain MAO-B in humans after Ro 19-6327 are likely to be faithfully reflected by platelet MAO activity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Da Prada M, Kettler R, Keller HH, Burkard WP (1988) Ro 19-6327, a reversible, highly selective inhibitor of type B monoamine oxidase, completely devoid of tyramine-potentiating effects: comparison with selegiline. In: Sandler M, Dahlström A, Belmaker RH (eds) Progress in catecholamine research, part B. Central aspects. Alan R Liss, New York, pp 359–363.

    Google Scholar 

  • Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 248:400–414.

    PubMed  Google Scholar 

  • Kettler R, Da Prada M (1989) Platelet MAO-B activity in humans and stumptail monkeys: in vivo effects of the reversible MAO-B inhibitor Ro 19-6327. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 213–219.

    Chapter  Google Scholar 

  • Oreland L, Johanson F, Ekstedt J (1983) Dose regimen of deprenyl (selegiline) and platelet MAO activities. Acta Neurol Scand [Suppl] 95:87–89.

    Article  CAS  Google Scholar 

  • Price GW, Bench CJ, Cremer JC, Luthra SK, Turton DR, Lammertsma AA, Kettler R, Da Prada M, Wood N, Jamieson V, McClelland G, Frackowiak RSJ (1990) Inhibition of human brain monoamine oxidase-B by Ro 19-6327 — in vivo measurement using positron emission tomography. Eur J Pharmacol 183: 166.

    Article  Google Scholar 

  • Riederer P, Youdim MBH, Rausch WD, Birkmayer W, Jellinger K, Seemann D (1978) On the mode of action of L-deprenyl in the human central nervous system. J Neural Transm 43:217–226.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag

About this paper

Cite this paper

Kettler, R., Cesura, A.M., Dingemanse, J., Da Prada, M. (1990). MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course. In: Riederer, P., Youdim, M.B.H. (eds) Amine Oxidases and Their Impact on Neurobiology. Journal of Neural Transmission, vol 32. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9113-2_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9113-2_31

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82239-5

  • Online ISBN: 978-3-7091-9113-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics